Physician profile
Randall Gary Samples
NPI 1699732115
$1,473.25
in general payments reported to CMS, 2019-2025
10 companies · $213 in 2025
The $213 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $66.22 · 2021: $216 · 2022: $216 · 2023: $131 · 2024: $509 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $677.78 | 2023-2025 | Qelbree, Qelbree, Oxtellar Xr |
| Cranial Technologies, INC | $233.50 | 2020-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $124.37 | 2019-2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $112.20 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $99.16 | 2019-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $89.90 | 2019-2025 | Bexsero |
| Corium, LLC | $58.55 | 2022-2023 | Azstarys |
| Genentech USA, INC. | $38.67 | 2019-2020 | |
| Pfizer INC. | $26.49 | 2019-2021 | |
| Shire North American Group INC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Samples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.